Action 524372 ORCHID PHARMA LIMITED
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Orchid Pharma Limited Bombay S.E.

Actions

524372

INE191A01027

Marché Fermé - Bombay S.E.
Autres places de cotation
 12:00:49 29/04/2024 		Varia. 5j. Varia. 1 janv.
1 086 INR +0,16 % Graphique intraday de Orchid Pharma Limited +3,23 % +52,23 %
12/04 Orchid Pharma Limited annonce la démission de Mudit Tandon en tant qu'administrateur indépendant CI
23/02 Orchid Pharma reçoit l'approbation de la Food and Drug Administration des États-Unis pour sa nouvelle invention CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Orchid Pharma Limited Announces Resignation of Mudit Tandon as Independent Director
Orchid Pharma : Iii. Un-audited Financial Results for the quarter ended December 31, 2023 - Dec 31,2023
Orchid Pharma : Un-audited Financial Results for the quarter ended June 30, 2023 - June 30,2023
Orchid Pharma : Un-audited Financial Results for the quarter and half year ended September 30, 2023 - Sep 30,2023
Orchid Pharma Receives United States Food and Drug Administration Approval for Its Novel Invention
Orchid Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
European Medicines Agency Grants Approval for Orchid Pharma's 'Exblifep'
Orchid Pharma Limited Appoints Kapil Dayya as Company Secretary & Compliance Officer
Orchid Pharma Limited Announces Resignation of Marina Peter as Company Secretary and Compliance Officer
Orchid Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Orchid Pharma Limited Approves the Appointment of Mr. Arjun Dhanuka as Additional Director (In Capacity of Non-Executive & Non-Independent)
Orchid Pharma Ties Up with GARDP to Manufacture Antibiotic for Certain Gram-Negative Infections
Orchid Pharma Limited Enters into Manufacturing Sub License Agreement with Global Antibiotic Research & Development Partnership
Orchid Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Orchid Pharma : Notice of 30th AGM.
Orchid Pharma : Annual Report 2022-2023
Orchid Pharma Raises INR4 Billion Via Qualifed Institutional Placement
Orchid Pharma : NOMINATION AND REMUNERATION POLICY
Orchid Pharma : Audited Financial Result for the quarter and Financial year ended March 31, 2023 - May 10,2023
Orchid Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action ORCHPHARMA
  4. Action 524372
  5. Actualités Orchid Pharma Limited
  6. Autres langues